Mindfully Curated
Flexible displays that can change color, convey information and even send veiled messages via infrared radiation are now possible, thanks to new research. Engineers inspired by the morphing skins of animals like chameleons and octopuses have developed …
Researchers have identified a potential new immune checkpoint receptor that could lead to treatments for diseases such as lung and bowel cancer and autoimmune conditions including IBD.
A team of scientists from around the globe has gained high-res structural insights into a key bacterial enzyme, which may help chemists design new drugs to inhibit it and thus suppress disease-causing bacteria. Their work is important as fears continue…
Scientists have successfully tested a novel way of boosting honey bees’ immune systems to help them fend off deadly viruses, which have contributed to the major losses of the critical pollinator globally.
The universe is expanding; we’ve had evidence of that for about a century. But just how quickly celestial objects are receding from each other is still up for debate.
The return of a theme park resort promotion, an iconic festival, and a big theatrical release will make this an interesting month for Disney shareholders.
Comcast’s quick move to monetize its intellectual property could be a mistake in the long run.
Amazon has had a troubling year, but it’s making promising inroads in generative AI that could pay off in the long run.
These companies should have no problem continuing to pay their dividends in the coming years.
This stock offers steady growth, a huge dividend, and multiple ways to make you money over the coming years.
Here are seven stocks to buy now that could unlock explosive gains in your growth-stock portfolio.
Here’s everything you need to know about the electric vehicle (EV) maker’s week.
The company can turn a relatively small investment into an attractive passive income stream.
Wall Street might have the timing wrong, but their hopes aren’t misplaced.
“One Up on Wall Street” is worth a read.
It’s all about quality over the valuation when it comes to this thriving company.
Alibaba shuffles the deck as it heads toward spinning off its cloud division.
While it’s not a guarantee that you can beat the market, you certainly have better chances than the pros.
Pfizer’s long-term potential shows promise, but concerns exist.
Stocks are soaring on artificial intelligence hype, but these two are old hands when it comes to AI.